Aug. 16, 2013
(Nasdaq: ARAY), announced today its participation in the 22
China International Medical Instruments and Equipment Exhibition and Seminar (
-HOSPEQ), taking place from
Friday, August 16
Sunday, August 18, 2013
For the first time,
hospital procurement officials will be able to see firsthand Accuray's CyberKnife and TomoTherapy Systems at
-HOSPEQ 2013 (booth #G02). On display in the booth will be system models and demonstration stations featuring various products and clinical illustrations. PLA General Hospital and Peking Union Medical College Hospital in
are leading the charge with these new technologies, having already acquired the CyberKnife and TomoTherapy Systems. PLA General Hospital is the first and only
hospital with both systems. Cancer is one of the leading causes of mortality in
, with almost two million cancer deaths nationwide during 2008. The
Systems give physicians in
the most innovative and precise treatment solutions to help make the pain and suffering of cancer a thing of the past, and provide new hope to more cancer patients.
"We are committed to strengthening our partnerships in
, with the government and distributors, to offer more patients the opportunity to benefit from our effective, personalized treatments," said
, executive vice president and chief commercial officer at Accuray.
"Our factory in
produces the TomoTherapy System's linear accelerators (linacs) for the global market. Accuray continues to invest in this factory with new machinery, and is continuing to further our commitment to quality, evidenced by the factory's ISO 9001 accreditation," said
president at Accuray.
The TomoTherapy System is the only radiation therapy system designed specifically for image-guided, intensity-modulated radiation therapy. Its on-board CT scanner enables daily pre-treatment imaging for increased accuracy and the system's linear accelerator (linac) enables the continuous helical delivery of radiation from 360 degrees around the patient, providing for increased treatment precision.